Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Osiris Therapeutics, Inc.    OSIR

OSIRIS THERAPEUTICS, INC. (OSIR)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/17/2018 05/18/2018 05/21/2018 05/22/2018 05/23/2018 Date
7.65(c) 7.64(c) 7.7(c) 7.61(c) 7.85(c) Last
149 702 1 668 8 881 15 332 10 296 Volume
-1.92% -0.13% +0.79% -1.17% +3.15% Change
More quotes
Company
Osiris Therapeutics, Inc. engages in stem cell research and development of pharmaceutical products.Its regenerative medicine targets dermal burns, pressure ulcers, venous leg, diabetic foot ulcers, as well as tissue and bone repair.The company was founded by Peter A. Friedli and James S. Burns on... 
More about the company
Latest news on OSIRIS THERAPEUTICS, INC.
05/10OSIRIS THERAPEUTICS : Management's Discussion and Analysis of Financial Conditio..
AQ
05/10OSIRIS THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
04/30OSIRIS THERAPEUTICS : Announces New Peer-Reviewed Publication Summarizing Clinic..
AQ
04/25OSIRIS THERAPEUTICS : to Present Clinical and Scientific Studies at Symposium on..
AQ
04/19OSIRIS THERAPEUTICS, INC. : Other Events (form 8-K)
AQ
03/28OSIRIS THERAPEUTICS : Management's Discussion and Analysis of Financial Conditio..
AQ
02/08OSIRIS THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
02/07OSIRIS THERAPEUTICS : Fifth CEO of Osiris Therapeutics since 2016 to resign on F..
AQ
02/07OSIRIS THERAPEUTICS : Appoints Willi Miesch to its Board of Directors, Change in..
AQ
02/06OSIRIS THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
More news
Sector news : Bio Therapeutic Drugs
05/18GLAXOSMITHKLINE : Regulators flag possible birth defect link to GSK's HIV drug
RE
05/11Trump's Plan to Cut Drug Prices Leaves Industry Relieved
DJ
05/09Drugmaker GSK rings in more change as CFO heads for exit in 2019
RE
05/08UK biotech firm Autolus joins CAR-T rush with Nasdaq IPO filing
RE
05/03Teva raises 2018 outlook, expects migraine drug approval by year-end
RE
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
04/09OSIRIS THERAPEUTICS : Regenerated 
02/22HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am (2/22/2018) 
02/22MIMEDX : Do The Numbers Support Channel Stuffing Accusations? 
02/08BIOLIFE SOLUTIONS : A Diversified, Profitable Play On Gene Therapy And Regenerat.. 
02/07HEALTHCARE GAINERS / LOSERS AS OF 11 : 00 am (2/7/2018) 
Chart OSIRIS THERAPEUTICS, INC.
Duration : Period :
Osiris Therapeutics, Inc. Technical Analysis Chart | OSIR | US68827R1086 | 4-Traders
Income Statement Evolution
Managers
NameTitle
Linda S. Palczuk President & Chief Executive Officer
Peter A. Friedli Chairman
Frank D. Czworka Chief Operating Officer
Joel Rogers Chief Financial Officer
Alla Danilkovitch Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
OSIRIS THERAPEUTICS, INC.28.33%263
GILEAD SCIENCES-5.60%88 197
VERTEX PHARMACEUTICALS4.24%39 825
REGENERON PHARMACEUTICALS-19.72%31 221
GENMAB19.78%11 932
BEIGENE LTD (ADR)97.99%10 364